You are here: Industry Insights > funding

News List

JHL Biotech raises $106M in pre-IPO funding biospectrumasia
May 31, 2018
JHL will allocate its new capital to support clinical trials and further development of its biosimilar portfolio.
Portland immunotherapy startup tops $10M in funding as it launches first clinical trial firstwordpharma
May 30, 2018
Emmanuel Akporiaye, founder of Veana Therapeutics, said the start-up raised its first venture funding, a $542 000 seed round that brings its total funding to more than $10 million, reported GeekWire
Discngine receives €600,000 funding from Bpifrance biospectrumasia
May 15, 2018
Funding will enable company to conduct research program on collaborative large scale three-dimensional data management for biomolecules
Refuge Biotechnologies secures $25M funding from Chinese investors biospectrumasia
May 07, 2018
The fund will be used to continue developing cell therapy programs based on Refuge's receptor-dCas platform.
Innovent secures funding worth $150M biospectrumasia
May 02, 2018
The proceeds will be used to speed up and expand the company's clinical programs.
Corvidia Therapeutics Secures $60 Million in Series B Funding to Accelerate Clinical Work biospace
April 26, 2018
Corvidia Therapeutics Inc., a leading clinical stage biotechnology company, today announced the close of a $60 million USD Series B funding round.
Corvidia Raises $60 Million Series B to Push into the Clinic biospace
April 26, 2018
Corvidia Therapeutics, headquartered in Waltham, Massachusetts, closed on a Series B funding round worth $60 million.
Vicarious Surgical Closes $16.75 Million in Series A Funding biospace
April 18, 2018
Vicarious Surgical today announced that it has closed a $16.75 million Series A funding round.
QurAlis Launches with Seed Funding from MPH, Amgen and Alexandria Venture americanpharmaceuticalreview
April 09, 2018
QurAlis announced the addition of biotech investors MP Healthcare Venture Management (MPH), Amgen Ventures, and Alexandria Venture Investments, who have joined to cure Amyotrophic Lateral Sclerosis (ALS)
BioConsortia Continues Growth and Success, Securing $10 Million in Series D Funding biospace
March 30, 2018
BioConsortia, Inc., has closed a further round of equity financing to support its continued growth, research achievements and development of superior products.

Previous page 1 2 3 4 5 6 Next page